皮肤扩张术Ⅰ期术后血肿诱因及防治策略的研究进展  

Research progress of inducing factors,prevention and treatment strategies of hematoma after one-stage tissue expansion

作　　者：何强 马显杰 He Qiang;Ma Xianjie(Department of Plastic Surgery,First Hospital Affiliated to Air Force Medical University,Xi’an 710032,China)

机构地区：[1]空军军医大学第一附属医院整形外科,西安710032

出　　处：《中华实验外科杂志》2022年第2期394-397,共4页Chinese Journal of Experimental Surgery

基　　金：国家自然科学基金(81971851、82172229)。

摘　　要：皮肤软组织扩张术经过40多年的发展革新, 现已广泛应用于整形外科领域, 但扩张器置入术后的并发症发生率仍然居高不下。其中扩张囊腔血肿是早期最常见的并发症, 且与感染、皮瓣坏死、包膜挛缩等其他并发症的发生关联紧密, 严重影响重建效果。本文通过回顾国内外相关文献, 从皮肤软组织扩张术Ⅰ期术后血肿的诱因、预防、治疗等三个方面进行综述。After more than 40 years of development and innovation,skin and soft tissue expansion has been widely used in the field of plastic surgery,but the incidence of postoperative complications after expander implantation is still high.Expansion capsule hematoma is the most common complication in the early stage,and is closely associated with infection,flap necrosis,capsular contracture and other complications,seriously affecting the effect of reconstruction.This article reviews the related literatures at home and abroad,and reviews the causes,prevention and treatment of postoperative hematoma in stage I of skin and soft tissue expansion.

关 键 词：皮肤软组织扩张术 并发症 血肿 扩张器 

分 类 号：R622[医药卫生—整形外科]